Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0001628280-25-048858

Chief Financial Officer sold 1,303 shares at $6.49 ($8,456)

  • Chief Financial Officer acquired 3,605 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kelly John Alexander Chief Financial Officer 2025-11-02 Option exercise 10b5-1 +3,605 78,601 D
Kelly John Alexander Chief Financial Officer 2025-11-03 Sale 10b5-1 −1,303 $6.49 $8,456 77,298 D
Derivatives
Kelly John Alexander Chief Financial Officer 2025-11-02 Option exercise · Restricted Stock Units 10b5-1 −3,605 0 D
Open-market sales · 1,303 sh · avg $6.49 · $8,456
Loading xslF345X05/wk-form4_1762290943.xml…